Page last updated: 2024-11-02

pioglitazone and Encephalopathy, Hepatic

pioglitazone has been researched along with Encephalopathy, Hepatic in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Research Excerpts

ExcerptRelevanceReference
" Chronic administration of pioglitazone could contract this effect of BDL on event frequency and interevent interval, though the difference with the sham group was still significant in the duration of action potential."1.43Alterations in the intrinsic electrophysiological properties of Purkinje neurons in a rat model of hepatic encephalopathy: Relative preventing effect of PPARĪ³ agonist. ( Aghaei, I; Dehpour, A; Haghani, M; Hajali, V; Shabani, M; Sheibani, V, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aghaei, I1
Hajali, V1
Dehpour, A1
Haghani, M1
Sheibani, V1
Shabani, M1

Other Studies

1 other study available for pioglitazone and Encephalopathy, Hepatic

ArticleYear
Alterations in the intrinsic electrophysiological properties of Purkinje neurons in a rat model of hepatic encephalopathy: Relative preventing effect of PPARĪ³ agonist.
    Brain research bulletin, 2016, Volume: 121

    Topics: Action Potentials; Animals; Biophysics; Disease Models, Animal; Electric Stimulation; Hepatic Enceph

2016